These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Simplifying drug regimens. HIV Hotline; 1998 Mar; 8(1):11. PubMed ID: 11365353 [TBL] [Abstract][Full Text] [Related]
13. Another take on when to start and how to succeed. Friedland GH AIDS Clin Care; 2001 Sep; 13(9):82. PubMed ID: 11547600 [No Abstract] [Full Text] [Related]
14. Pathogenesis of HIV-associated lipodystrophy. Wanke C AIDS Clin Care; 2000 Dec; 12(12):100. PubMed ID: 12211161 [No Abstract] [Full Text] [Related]
15. Patient adherence, not viral load now most important in HIV therapy. Rep Med Guidel Outcomes Res; 2000 Feb; 11(3):6-7. PubMed ID: 11768406 [No Abstract] [Full Text] [Related]
16. Improved AIDS treatments bring life and hope--at a cost. Brink S US News World Rep; 2001 Jan; 130(4):44-6. PubMed ID: 11211336 [No Abstract] [Full Text] [Related]
17. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Maggiolo F; Ravasio L; Ripamonti D; Gregis G; Quinzan G; Arici C; Airoldi M; Suter F Clin Infect Dis; 2005 Jan; 40(1):158-63. PubMed ID: 15614706 [TBL] [Abstract][Full Text] [Related]
18. Protease inhibitors at a glance... Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198 [TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy. Badía X; Podzamczer D; Moral I; Roset M; Arnaiz JA; Loncà M; Casiró A; Rosón B; Gatell JM; Antivir Ther; 2004 Dec; 9(6):979-85. PubMed ID: 15651756 [TBL] [Abstract][Full Text] [Related]
20. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up. Negredo E; Paredes R; Bonjoch A; Tuldrà A; Fumaz CR; Gel S; Garcés B; Johnston S; Arnó A; Balagué M; Jou A; Tural C; Sirera G; Romeu J; Cruz L; Francia E; Domingo P; Arrizabalaga J; Ruiz I; Arribas JR; Ruiz L; Clotet B Antivir Ther; 1999; 4 Suppl 3():23-8. PubMed ID: 16021868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]